Please try another search
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Kevin Flaherty | - | 2021 | Member of Clinical Advisory Board |
Marlies Wijsenbeek | - | 2021 | Member of Clinical Advisory Board |
Kiran Mazumdar-Shaw | 70 | 2020 | Independent Non-Executive Director |
Williamson Z. Bradford | 61 | 2021 | Member of Clinical Advisory Board |
Toby Maher | - | 2021 | Member of Clinical Advisory Board |
Vincent Cottin | - | 2021 | Member of Clinical Advisory Board |
Paul W. Noble | - | 2021 | Member of Clinical Advisory Board |
Raju S. Kucherlapati | 80 | 2014 | Interim Chair & Senior Independent Director |
Bennett M. Shapiro | 84 | 2020 | Board Advisor |
Robert S. Langer | 75 | 2015 | Co-Founder & Non-Executive Director |
Maurizio Fava | - | - | Advisor |
Colin R. Gardner | - | - | Advisor |
Adam Gazzaley | 54 | - | Advisor |
H. Robert Horvitz | - | 2015 | Board Observer |
Frederick Frank | 92 | - | Senior Advisor |
Joseph W. St. Geme | - | 2016 | Advisor |
Robert Zatorre | - | - | Advisor |
Tristan Jehan | - | - | Advisor |
Mark S. George | - | - | Advisor |
Samir Mitragotri | - | - | Advisor |
Robert M. Post | - | - | Advisor |
Philip Just Larsen | - | 2016 | Senior Advisor |
Angelo Tremblay | - | 2016 | Advisor |
Siddhartha Mukherjee | 53 | 2016 | Advisor |
Julien Epps | - | 2016 | Advisor |
George Cotsarelis | - | - | Advisor |
Jeff Conn | - | - | Advisor |
B. Brett Finlay | - | - | Advisor |
Alan Breier | - | 2016 | Advisor |
Feng Zhang | - | 2016 | Advisor |
Sam Kass | - | 2016 | Advisor |
Robert T. Schultz | - | 2016 | Advisor |
Sharon Barber-Lui | 49 | 2022 | Independent Non-Executive Director |
Donald E. Ingber | - | 2016 | Senior Advisor |
John L. LaMattina | 74 | 2009 | Independent Non-Executive Director |
Arne V. Astrup | - | - | Advisor |
Alberto Recordati | 71 | - | Advisor |
Howard B. Rosen | 66 | - | Advisor |
Alexander Rudensky | - | - | Advisor |
Scott H. Kollins | - | 2016 | Advisor |
Derrick J. Rossi | - | 2016 | Advisor |
Aimee Danielson | - | 2016 | Advisor |
Allan Geliebter | - | - | Advisor |
Michael B. Brenner | - | 2016 | Advisor |
Ian Gotlib | - | 2016 | Advisor |
Rob Knight | - | 2016 | Advisor |
Geraldine Dawson | - | 2016 | Advisor |
Daphne Zohar | 53 | 2015 | Founder, Senior Advisor & Board Observer |
R. Rox Anderson | 73 | 2016 | Advisor |
James J. Collins | 57 | 2015 | Advisor |
Rakesh K. Jain | 74 | - | Advisor |
Caroline M. Apovian | - | - | Advisor |
David R. Elmaleh | 76 | - | Co-Founder & Senior Advisor |
Ruslan Medzhitov | - | - | Advisor |
Kenya Honda | - | - | Advisor |
Joseph C. Kvedar | - | - | Advisor |
David A. Edwards | 63 | 2016 | Advisor |
Edward S. Boyden | - | 2016 | Advisor |
Dennis Arthur Ausiello | 79 | 2015 | Board Advisor |
Ralph Weissleder | - | 2016 | Advisor |
Jeffrey M. Karp | - | 2016 | Advisor |
Ken Fujioka | - | 2016 | Advisor |
Bharatt M. Chowrira | 59 | 2017 | CEO & Executive Director |
Louis J. Aronne | 68 | 2016 | Advisor |
Daphne Bavelier | - | - | Advisor |
Robert J. Perez | 60 | 2016 | Senior Advisor |
James Oakley Hill | - | - | Advisor |
Lee M. Kaplan | - | - | Advisor |
Daniel R. Littman | 71 | - | Advisor |
Helen Christensen | - | 2016 | Advisor |
Martin J. Blaser | - | 2016 | Advisor |
Ulrich H. von Andrian-Werburg | - | 2016 | Advisor |
Maria Gloria Dominguez-Bello | - | 2016 | Advisor |
Stephen V. Faraone | - | 2016 | Advisor |
Steven H. Holtzman | 70 | 2016 | Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review